Timothy J. Hahn, Timothy J. Hahn, Daniel J. McKeone, Daniel J. McKeone, James W. Beal, Jessica E. Ericson, . . . E. Scott Halstead. (2024). Case Report: Successful avoidance of etoposide for primary hemophagocytic lymphohistiocytosis-induced multiple organ dysfunction syndrome using emapalumab. Frontiers Media S.A..
Chicago Style (17th ed.) CitationTimothy J. Hahn, Timothy J. Hahn, Daniel J. McKeone, Daniel J. McKeone, James W. Beal, Jessica E. Ericson, Jessica E. Ericson, E. Scott Halstead, and E. Scott Halstead. Case Report: Successful Avoidance of Etoposide for Primary Hemophagocytic Lymphohistiocytosis-induced Multiple Organ Dysfunction Syndrome Using Emapalumab. Frontiers Media S.A., 2024.
MLA (9th ed.) CitationTimothy J. Hahn, et al. Case Report: Successful Avoidance of Etoposide for Primary Hemophagocytic Lymphohistiocytosis-induced Multiple Organ Dysfunction Syndrome Using Emapalumab. Frontiers Media S.A., 2024.